Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
General Oncology, Inc. See All Filings	D/A	2025-07-02 15:44:12 UTC
Amount To Be Raised $17,325,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-25-000002 Exclusions or Exemptions 506b Accepted Date 2025-07-02 15:44:12 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2024-07-02 13:54:25 UTC
Amount To Be Raised $11,250,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-07-02 13:54:25 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2023-12-21 11:08:46 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-23-000001 Exclusions or Exemptions 506b Accepted Date 2023-12-21 11:08:46 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2022-12-22 14:14:10 UTC
Amount To Be Raised $7,500,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-12-22 14:14:10 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2022-11-10 14:47:10 UTC
Amount To Be Raised $3,750,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-11-10 14:47:10 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2021-11-10 11:55:38 UTC
Amount To Be Raised $3,750,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-11-10 11:55:38 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2020-07-14 17:08:16 UTC
Amount To Be Raised $1,250,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-07-14 17:08:16 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D	2019-07-09 16:39:27 UTC
Amount To Be Raised $1,250,000 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-07-09 16:39:27 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D/A	2017-09-05 15:49:25 UTC
Amount To Be Raised $46,905,641 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-09-05 15:49:25 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
General Oncology, Inc. See All Filings	D	2015-11-16 00:00:00 UTC
Amount To Be Raised $46,905,641 Associated Brokers / Dealers N/A CIK Number 0001658021 Filed Document 0001658021-15-000001 Exclusions or Exemptions 506b Accepted Date 2015-11-16 00:00:00 UTC Type of Offering D Industry Biotechnology Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity